A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment for SARS-СoV-2 infection in the United Arab Emirates

  • Ahmed A.K. AlHammadi
  • , Amna H. Alzaabi
  • , Haneen B. Choker
  • , Ahmed A. Ibrahim
  • , Asma Bin Ishaq
  • , Ahmed E. Mahboub
  • , Reem S. Al Dhaheri
  • , Mohamed N. Alzaabi
  • , Timothy A. Collyns
  • , Gehad ElGhazali
  • , Stefan Weber
  • , Basel K. Al-Ramadi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment for SARS-СoV-2 infection in the United Arab Emirates'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology